Trials / Completed
CompletedNCT05190107
Depression, Anxiety and Stress in High School
Prevalence of Depression, Anxiety and Stress in High School Students: A Survey Study in Western Mexico
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,112 (actual)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- All
- Age
- 14 Years – 22 Years
- Healthy volunteers
- Accepted
Summary
Background: Social isolation secondary to the pandemic can predispose the population to mental health issues in the future, especially teenagers. The Depression, Anxiety, and Stress Scale (DASS) is a valuable self-report scale since it may be used to screen for anxiety, depression, and stress in one questionnaire. In the last years, it has been observed effective in detecting these symptoms in teenagers. Aims: Identify the prevalence of depression, anxiety, and stress in high school students during the COVID-19 pandemic This is an observational cross-sectional study. For this study, the validated Spanish version of DASS-21 will be used. Qualitative variables will be evaluated through central tendencies, such as mean, standard deviation, and frequencies. The inferential analysis of categorical variables will be performed using the chi-squared test, analysis of variance (ANOVA), or Kruskal Wallis test as appropriate. For quantitative variables, Student's t-test or Mann Whitney U test will be performed depending on their distribution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | DASS-21 scale | Each construct consists of 7 questions. The participants must select the answer that better represents their feelings over the last week in each scenario. Each question has a Likert scale of 4 options where 0 represents "did not apply to me" to 3 "applied to me very much. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2021-11-01
- Completion
- 2021-12-10
- First posted
- 2022-01-13
- Last updated
- 2022-01-13
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT05190107. Inclusion in this directory is not an endorsement.